Filing Details

Accession Number:
0001140361-23-035288
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-19 21:33:35
Reporting Period:
2023-07-18
Accepted Time:
2023-07-19 21:33:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1743881 Bridgebio Pharma Inc. BBIO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1103804 Viking Global Investors Lp 55 Railroad Avenue
Greenwich CT 06830
No No No No
1133006 Andreas Ole Halvorsen 55 Railroad Avenue
Greenwich CT 06830
No No No No
1621842 C. David Ott 55 Railroad Avenue
Greenwich CT 06830
No No No No
1629472 Viking Global Opportunities Portfolio Gp Llc 55 Railroad Avenue
Greenwich CT 06830
No No No No
1629476 Viking Global Opportunities Gp Llc 55 Railroad Avenue
Greenwich CT 06830
No No No No
1629482 Viking Global Opportunities Illiquid Investments Sub-Master Lp 55 Railroad Avenue
Greenwich CT 06830
No No No No
1711393 Sharon Rose Shabet 55 Railroad Avenue
Greenwich CT 06830
No No No No
1886738 Viking Global Opportunities Parent Gp Llc 55 Railroad Avenue
Greenwich CT 06830
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-07-18 1,500,000 $35.00 25,120,991 No 4 S Indirect See Explanation of Responses
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Explanation of Responses
Footnotes
  1. All shares were sold on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP ("Opportunities Fund"). Viking Global Opportunities Portfolio GP LLC ("Opportunities Portfolio GP") is the general partner of Opportunities Fund. Viking Global Opportunities GP LLC ("Opportunities GP") is the sole member of Opportunities Portfolio GP. Viking Global Opportunities Parent GP LLC ("Parent") is the sole member of Opportunities GP. Because of the relationship between each of Opportunities Portfolio GP, Opportunities GP, Parent and Opportunities Fund, each of Opportunities Portfolio GP, Opportunities GP and Parent may be deemed to beneficially own the shares held directly by Opportunities Fund.
  2. This amount includes 631,167 shares of Common Stock held directly by Viking Global Equities Master Ltd. ("VGEM"), 251,204 shares of Common Stock held directly by Viking Long Fund Master Ltd. ("VLFM"), and 24,238,620 shares of Common Stock held directly by Opportunities Fund.
  3. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP ("VGI"), Viking Global Performance LLC ("VGP"), which provides managerial services to VGEM, Viking Long Fund GP LLC ("VLFGP"), which provides managerial services to VLFM, and Parent. VGI provides managerial services to various investment funds and vehicles, including VGEM, VLFM, and Opportunities Fund.
  4. Because of the relationship between VGI and each of VGEM, VLFM and Opportunities Fund, VGI may be deemed to beneficially own the shares held directly by VGEM, VLFM and Opportunities Fund. Each of VGI, Mr. Halvorsen, Mr. Ott and Ms. Shabet may be deemed to beneficially own all of the securities reported on this form.
  5. The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.